Robert Califf’s FDA nomination is approved at committee stage

Readers with interests in the regulation of e-cigarettes in the US can learn about the questioning of Robert Califf in the Senate Committee on Health, Education, Labor, and Pensions. Califf is nominated for the powerful position of commissioner of the Food and Drug Administration.

In the hearing he faced questions from US senators about his views on tobacco and synthetic nicotine policies.

Both anti-tobacco and pro-vaping advocates have ommented their views on Califf’s nomination.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ Robert Califf’s FDA nomination is approved at committee stage ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ Robert Califf’s FDA nomination is approved at committee stage ”






      Readers with interests in the regulation of e-cigarettes in the US can learn about the questioning of Robert Califf in the Senate Committee on Health, Education, Labor, and Pensions. Califf is nominated for the powerful position of commissioner of the Food and Drug Administration.

      In the hearing he faced questions from US senators about his views on tobacco and synthetic nicotine policies.

      Both anti-tobacco and pro-vaping advocates have ommented their views on Califf’s nomination.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik